期刊文献+

lncRNA Hulc和miR-9-5p在乳腺癌中的表达水平及临床意义 被引量:5

Expression and clinical significance of lncRNA Hulc and miR-9-5p in breast cancer
下载PDF
导出
摘要 目的检测乳腺癌组织中长链非编码RNA肝癌高表达转录本(lncRNA Hulc)、微小RNA-9-5p(miR-9-5p)的表达情况,探讨两者对乳腺癌淋巴结转移的预测价值。方法收集2017年1月至2019年1月贺州市人民医院诊治的80例乳腺癌患者的乳腺癌组织及其癌旁组织,应用实时荧光定量PCR检测乳腺癌组织和癌旁组织中lncRNA Hulc、miR-9-5p的表达水平;分析lncRNA Hulc、miR-9-5p的表达与乳腺癌患者临床病理参数的关系;采用Pearson相关性分析lncRNA Hulc与miR-9-5p表达的相关性,采用受试者工作特征(ROC)曲线分析lncRNA Hulc和miR-9-5p对乳腺癌淋巴结转移的预测价值。结果乳腺癌组织中的lncRNA Hulc表达水平高于癌旁组织,miR-9-5p表达水平低于癌旁组织,差异均有统计学意义(P<0.05);T3+T4期、Ⅲ+Ⅳ期及有淋巴结转移乳腺癌患者的lncRNA Hulc表达水平分别高于T1+T2、Ⅰ+Ⅱ期及无淋巴结转移者,Ⅲ+Ⅳ期、有淋巴结转移乳腺癌患者的miR-9-5p表达水平分别低于Ⅰ+Ⅱ期、无淋巴结转移者,差异均有统计学意义(P<0.05)。乳腺癌组织中lncRNA Hulc与miR-9-5p的表达呈负相关(r=-0.472,P=0.003)。lncRNA Hulc和miR-9-5p对乳腺癌淋巴结转移均有一定的预测价值,ROC曲线下面积均>0.7。二者联合应用的预测价值更高,敏感度和特异度分别为0.818、0.809。结论lncRNA Hulc在乳腺癌组织中表达增加,miR-9-5p在乳腺癌组织中表达下调,lncRNA Hulc和miR-9-5p的表达均与乳腺癌患者的不良病理参数相关,且对淋巴结转移有一定的预测价值。lncRNA Hulc、miR-9-5p可能是乳腺癌的治疗靶标。 Objective To detect the expression of long non-coding RNA highly upregulated in liver cancer(lncRNA Hulc)and microRNA-9-5p(miR-9-5p)in breast cancer tissues,and to explore the predictive value of both for lymph node metastasis of breast cancer.Methods 80 cases of breast cancer tissues and their adjacent tissues were collected from the patient with breast cancer who were treated in Hezhou people's hospital from January 2017 to January 2019,and quantitative real-time PCR was used to detect expression levels of lncRNA Hulc and miR-9-5p in breast cancer and adjacent tissues.The relationship between lncRNA Hulc,miR-9-5p expression and clinicopathological parameters of patients with breast cancer were analyzed.Pearson correlation was used to analyze the expression of lncRNA Hulc and miR-9-5p,and receiver operation characteristic(ROC)curve was used to analyze the predictive value of lncRNA Hulc and miR-9-5p in lymph node metastasis of breast cancer.Results The expression level of lncRNA Hulc in breast cancer was higher than that in the adjacent tissues,and the expression level of miR-9-5p was lower than that in the adjacent tissues,the difference was statistically significant(P<0.05).The expression of lncRNA Hulc in patient with stage T3+T4,stageⅢ+Ⅳor with lymph node metastasis was significantly higher than that in patient with stage T1+T2,stageⅠ+Ⅱor without lymph node metastasis,the expression level of miR-9-5p in patients with stageⅢ+Ⅳor with lymph node metastasis was lower than that in patients with stageⅠ+Ⅱor without lymph node metastasis,the difference was statistically significant(P<0.05).There was a negative correlation between lncRNA Hulc and miR-9-5p expression in breast cancer tissues(r=-0.472,P=0.003).LncRNA Hulc and miR-9-5p had a certain predictive value for lymph node metastasis of breast cancer,and the area under ROC curve was greater than 0.7.The prediction value of the combination of the two was higher,and the sensitivity and specificity were 0.818 and 0.809 respectively.Conclusions The
作者 黄振宇 杨剑波 凌雪君 赖万强 李艳华 HUANG Zhenyu;YANG Jianbo;LING Xuejun;LAI Wanqiang;LI Yanhua(Department of Thyroid and Breast Surgery, Hezhou People's Hospital, Hezhou 542899,China)
出处 《中国肿瘤外科杂志》 CAS 2020年第4期360-365,共6页 Chinese Journal of Surgical Oncology
关键词 乳腺癌 RNA 长链非编码 肝癌高表达转录本 微小RNA-9-5p 临床病理参数 Breast cancer RNA,long noncoding High up-regulated in liver cancer MiR-9-5p Clinicopathological parameters
  • 相关文献

参考文献5

二级参考文献17

  • 1王晓稼,郑树,彭佳萍,吴金民.乳腺癌患者ST13、Hsp70、pS2、雌激素受体和孕激素受体表达及其与生存的关系[J].中华实验外科杂志,2005,22(9):1071-1073. 被引量:7
  • 2Balch CM, Singletary SE, Bland KI. Clinical decision-making in early breast cancer[J]. Ann Surg, 1993, 217(3):207-225. 被引量:1
  • 3Cochrane RA, Valasiadou P, Wilson AR, et al. Cosmesis and satisfaction after breast- conserving surgery correlates with the percentage of breast volume excised[J]. Br J Surg, 2003, 90 (12):1505-1509. 被引量:1
  • 4Wang HT, Barone CM, Steigelman MB, et al. Aesthetic outcomes in breast conservation therapy[J]. Aesthet Surg J, 2008, 28(2):165- 170. 被引量:1
  • 5Sherwell-Cabello S, Maffuz-Aziz A, Villegas-Carlos F. Feasibility and cosmetic outcome of oncoplastic surgery in breast cancer treatment[J]. Cir Cir, 2015, 83f3}:199-205. 被引量:1
  • 6Chan 5W, Chueng P5, Lam SH. Cosmetic outcome and percentage of breast volume excision in oncoplastic breast conserving surgery[J]. World J Surg, 2010, 34f7}:1447-1452. 被引量:1
  • 7Losken A, Dugal CS, Styblo TM, et al. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique[J]. Ann Plas Surg, 2014, 72f2}:145-149. 被引量:1
  • 8Clough KB, Lewis JS, Couturaud B, et al. Oncoplastic techniques allow extensive resections for breast- conserving therapy of breast carcinomas[J]. Ann Surg, 2003, 237f1}:26-34. 被引量:1
  • 9Rietjens M, Urban CA, Rey PC, et al. Long-term oncological results of breast conservative treastment with oncoplastic sugery[J]. Breast, 2007, 16f4}:387-395. 被引量:1
  • 10Losken A, Styblo TM, Carlson GW, et al. Management algorithm and outcome evaluation of partial mastectomy defects treasted using reducation or mastopexy techniques[J]. Ann Plast Surg, 2007, 59f3}:235-242. 被引量:1

共引文献130

同被引文献42

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部